BioCardia, Inc.BCDANASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank47
3Y CAGR-1.9%
5Y CAGR-23.3%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-1.9%/yr
vs -25.3%/yr prior
5Y CAGR
-23.3%/yr
Recent acceleration
Acceleration
+23.4pp
Accelerating
Percentile
P47
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $4.17M | +13.5% |
| 2024 | $3.67M | -16.5% |
| 2023 | $4.39M | -0.5% |
| 2022 | $4.42M | -66.0% |
| 2021 | $13.01M | -17.0% |
| 2020 | $15.67M | +7.6% |
| 2019 | $14.56M | +2.5% |
| 2018 | $14.21M | +16.5% |
| 2017 | $12.19M | +63.9% |
| 2016 | $7.44M | - |